Search

Author/Creator Berak, H.

1. Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study. Issue 11 (3rd July 2018)

Authors:
Flisiak, R.; Janczewska, E.; Łucejko, M.; Karpińska, E.; Zarębska‐Michaluk, D.; Nazzal, K.; Bolewska, B.; Białkowska, J.; Berak, H.; Fleischer‐Stępniewska, K.; Tomasiewicz, K.; Karwowska, K.; Simon, K.; Piekarska, A.; Tronina, O.; Tuchendler, E.; Garlicki, A.
Journal:
Journal of viral hepatitis
Issue:
Volume 25:Issue 11(2018)
Page Start:
1298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study. Issue 6 (2nd June 2020)

Authors:
Piekarska, A.; Jabłonowska, E.; Garlicki, A.; Sitko, M.; Mazur, W.; Jaroszewicz, J.; Czauz-Andrzejuk, A.; Buczyńska, I.; Simon, K.; Lorenc, B.; Dybowska, D.; Halota, W.; Pawłowska, M.; Dobracka, B.; Berak, H.; Horban, A.; Tudrujek-Zdunek, M.; Tomasiewicz, K.; Janczewska, E.; Socha, Ł.
Journal:
AIDS care
Issue:
Volume 32:Issue 6(2020)
Page Start:
762
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study. Issue 9 (9th September 2016)

Authors:
Flisiak, R.; Janczewska, E.; Wawrzynowicz‐Syczewska, M.; Jaroszewicz, J.; Zarębska‐Michaluk, D.; Nazzal, K.; Bolewska, B.; Bialkowska, J.; Berak, H.; Fleischer‐Stępniewska, K.; Tomasiewicz, K.; Karwowska, K.; Rostkowska, K.; Piekarska, A.; Tronina, O.; Madej, G.; Garlicki, A.; Lucejko, M.; Pisula...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 9(2016)
Page Start:
946
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study. Issue 6 (6th February 2018)

Authors:
Flisiak, R.; Zarębska‐Michaluk, D.; Janczewska, E.; Staniaszek, A.; Gietka, A.; Mazur, W.; Tudrujek, M.; Tomasiewicz, K.; Belica‐Wdowik, T.; Baka‐Ćwierz, B.; Dybowska, D.; Halota, W.; Lorenc, B.; Sitko, M.; Garlicki, A.; Berak, H.; Horban, A.; Orłowska, I.; Simon, K.; Socha, Ł.
Journal:
Journal of viral hepatitis
Issue:
Volume 25:Issue 6(2018)
Page Start:
661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗